Cargando…
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
BACKGROUND: Although cervical cancer is often characterized as preventable, its incidence continues to increase in low‐ and middle‐income countries, underscoring the need to develop novel therapeutics for this disease.This study assessed the distribution of fusion genes across cancer types and used...
Autores principales: | Hiranuma, Kengo, Asami, Yuka, Kato, Mayumi Kobayashi, Murakami, Naoya, Shimada, Yoko, Matsuda, Maiko, Yazaki, Shu, Fujii, Erisa, Sudo, Kazuki, Kuno, Ikumi, Komatsu, Masaaki, Hamamoto, Ryuji, Makinoshima, Hideki, Matsumoto, Koji, Ishikawa, Mitsuya, Kohno, Takashi, Terao, Yasuhisa, Itakura, Atsuo, Yoshida, Hiroshi, Shiraishi, Kouya, Kato, Tomoyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524028/ https://www.ncbi.nlm.nih.gov/pubmed/37537783 http://dx.doi.org/10.1002/cam4.6415 |
Ejemplares similares
-
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2023) -
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
por: Kobayashi Kato, Mayumi, et al.
Publicado: (2022) -
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2022) -
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
por: Takayanagi, Daisuke, et al.
Publicado: (2021) -
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Kuno, Ikumi, et al.
Publicado: (2021)